Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership

Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership

Therapure Biopharma to perform fill/finish of nimotuzumab

Mississauga, ON (PRWEB) December 17, 2009

Thomas Wellner, President and CEO of Therapure Biopharma Inc. and David Allan, Chairman and CEO of YM BioSciences Inc. today announced the signing of an agreement under which Therapure Biopharma will provide aseptic fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM’s majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM). Under the terms of the agreement, Therapure will formulate and fill nimotuzumab into sterile vials in their aseptic GMP certified and Health Canada licensed fill suite in Mississauga, Canada. The facility is built to FDA, EMEA, MHRA and Health Canada standards. The final product will be utilized by YM BioSciences and its licensees, Daiichi Sankyo in Japan, Kuhnil in South Korea, and Oncoscience AG in Europe for all activities and by Innogene Kalbiotech, YM’s licensee in Southeast Asia, for global clinical trials.

Nimotuzumab is a humanized monoclonal antibody that targets and binds to the epidermal growth factor receptor (EGFR), the well-validated oncology target. Nimotuzumab is currently being evaluated in 32 clinical studies worldwide in numerous indications, including multiple stages of non-small cell lung cancer, pediatric and adult glioma, esophageal cancer, pancreatic cancer, gastric cancer and head & neck cancer. Three Phase III trials and eight Phase II trials of those 32 are being conducted between YM and its four licensees. Nimotuzumab has been approved for marketing in 23 countries including Argentina, Brazil, China, India, Indonesia and, most recently, Mexico. In 2009, worldwide revenues for EGFR-targeting monoclonal antibodies are expected to approximate $2 billion.

“We have been very pleased with the performance of nimotuzumab during our on-going clinical development program advancing it toward the market,” said David Allan. “Combining the supply of the active drug product from the Center Molecular Immunology with the fill/finish capabilities of Therapure’s manufacturing suite provides CIM and YM BioSciences with a cost-effective and complete Canadian solution that integrates the numerous skills required in the production of biologics and provides a North American GMP standard to the nimotuzumab manufacturing process. Our product is well suited to Therapure’s flexible and modern Health Canada-licensed facility.”

“Therapure Biopharma is proud to be able to work with YM BioSciences and to apply our expertise to support the clinical evaluation of this differentiated drug, and we look forward to continuing the process through supply of the commercial product when marketing authorizations are granted in the major markets,” said Thomas Wellner. “Therapure Biopharma has much experience filling and finishing a variety of biopharmaceutical products in different formats. Working closely with YM BioSciences, another successful Canadian-based biotech company, has allowed us to meet their quality requirements for a successful globalization of this exciting cancer treatment.”

The agreement has been concluded between Therapure Biopharma and YM BioSciences and the implementation of the agreement will occur upon the finalization of the contract agreed with CIM.

About Therapure Biopharma

Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins. As a contract development and manufacturing organization (CDMO) Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market for its’ clients. Therapure’s Health Canada licensed 130,000 sq. ft. facility, includes manufacturing, research and quality control laboratories and a cGMP warehouse, is built to U. S. FDA, EMEA, MHRA and Health Canada standards for the aseptic handling and purification of proteins.

For more information, please visit: www. therapurebio. com

Enquiries:
Thomas Wellner, President and CEO
Therapure Biopharma Inc.
+1 905 286-6204

About YM BioSciences

YM BioSciences Inc. is a life sciences product development company that identifies and advances a portfolio of promising cancer-related products at various stages of development. The Company is currently developing two late-stage products: nimotuzumab, an EGFR-targeting Affinity-Optimized Antibody™,and AeroLEF®,a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl. Products in clinical development at Cytopia Ltd., the Australian public company that, subject to shareholder agreement, shall be merged into YM, include a JAK 1/2-targeting small molecule (CYT387) in a Phase I clinical trial at Mayo Clinic and a novel vascular disrupting agent (CYT997) in a Phase I/II trial internationally. YM has proven regulatory and clinical trial expertise and a diversified business model designed to reduce risk while advancing clinical products toward international approval, marketing and commercialization. Nimotuzumab is licensed to CIMYM BioSciences Inc., the majority-owned Canadian subsidiary of YM. YM is acting on behalf of CIM to assure the technology transfer to Therapure and will manage the interaction with Therapure for the fill and finish.

Enquiries:
James Smith, the Equicom Group Inc. 
Tel. +1-416-815-0700 x 229 

Thomas Fechtner, the Trout Group LLC
Tel. +1-646-378-2931 

###

CELEBRITY SKIN CARE LINE, CLASSIC BEAUTY™, Nominated “Best in Beauty” 2004 by Health Magazine

CELEBRITY SKIN CARE LINE, CLASSIC BEAUTY™, Nominated “Best in Beauty” 2004 by Health Magazine.

CLASSIC BEAUTY™ skin care, nominated "Best in Beauty" 2004 by Health Magazine!

(PRWEB) May 26, 2004

(Burbank, CA) – Von Henschen Industries, Inc., creator of the scientifically advanced and entertainment industry preferred Classic Beauty™ skin care line, proudly announce their nomination by Health Magazine as one of 2004’s best products!

“We work hard to bring the best possible products to the marketplace.” Says Roni von Henschen, CEO, VHI, Inc. “With ingredients including Ester-C®, Laracare®, Vitamins A& E, and soothing botanicals, it is not a surprise, rather an honor to be nominated.”

Classic Beauty’s ™ “Best in Beauty” moisturizers combat the signs of aging and reduce acne. The oil-free and fragrance-free formulas are non-comedogenic and contain “The most effective ingredients available without a prescription”. It is fast, it is easy, it is affordable and it is effective. What more could you ask for?

To order the Classic Beauty™ skin care products, or to learn more about their innovative and cutting edge skin care line, visit the product website at www. classicbeauty. com

Knowledge Source, Inc. and Mark Farrah Associates Launch Health Insurer Insights

Knowledge Source, Inc. and Mark Farrah Associates Launch Health Insurer Insights

Health Insurer Insights is a company profile series that responds to the healthcare industry's need for competitive snapshots about leading health insurance companies. These reports are available online at www. knowsource. com

Trumbull, CT (PRWEB) June 29, 2006

Knowledge Source, Inc. and Mark Farrah Associates announced today that they have launched Health Insurer Insights which are available at knowsource. com (http://www. knowsource. com) or by calling 203-377-0460.

Knowledge Source's Health Insurer Insights, priced at $100, features a summary of recent corporate developments with strategy insights; health plan performance data; a competitor comparison; and a SWOT analysis.

Companies profiled to date include: Aetna, Assurant, CIGNA HealthCare, Coventry Health Care, Health Care Service Corporation, Health Net, Humana, Kaiser Permanente, UnitedHealth Group, and WellPoint.

Health Insurer Insights may be purchased as single profiles for $100 each, in quantities of 5 or more at a 15% discount, or on an annual subscription basis.

For additional information on Health Insurer Insights or other research reports published by Knowledge Source, please contact John Santilli at 203-377-0460 or visit Knowledge Source (http://www. knowsource. com) Health Insurer Insights are purchasable for $100 with immediate online delivery.

About Knowledge Source

Knowledge Source, headquartered in Trumbull, Connecticut, has been a leading source of healthcare business information and analyses since 1989. Products include Health Insurer Insights, Health Care Market Overviews and BusIntell Reports. The company also provides custom research services that include strategic opportunity assessment; market/industry analysis; competitive analysis; marketing and customer analysis; and survey research.

About Mark Farrah Associates

Mark Farrah Associates, headquartered in Kennebunk, Maine, provides health insurance market data and analysis. The company's portfolio includes online data products, industry-focused market reports and research consulting services. Since 1997, Mark Farrah Associates has been recognized as a leader in analyzing market data and trends. Products include Health Insurer Insights, Health Plans USA, Medicare Business Online, Medicare Advantage Market Reports, and Northeast Health Plans Online.

# # #

New Summer Fruit and Veg Offer is D. T. Brown's Biggest and Best

New Summer Fruit and Veg Offer is D. T. Brown's Biggest and Best

The newly released, 64 page Summer Fruit and Vegetables Catalogue 2010 from mail order kitchen garden specialist D. T. Brown is the company’s biggest-ever such offer.

(PRWeb UK) July 15, 2010

It features a host of new plants which are set to appeal to all those who enjoying growing and eating fresh, home-produced food. Following the immediate popularity of the honeyberry, which D. T. Brown introduced to British gardeners two years ago, comes the introduction of Juneberry Smoky (http://www. dtbrownseeds. co. uk/catalogue/product/juneberry-smoky-/61709), which has long been grown as a ‘pick-your-own’ crop in North America, where it is known as ‘saskatoon’.

Smoky’s fruits are similar in size, taste and shape to those of the blueberry and were once a staple food of North American Indians. The self-fertile, ultra-hardy plants will grow in most soils and can yield up to an impressive 4.5kg of fruit per bush in July. Unchecked plants can reach up to 2.5m high, whilst their suckering makes them good hedging plants. One bare-root plants costs £12.95, while three are offered for £28.85, a saving of £10.

Recently introduced self-fertile Kiwi arguta Issai is now joined by females Jumbo and Pupurna Sadowa and the male Weiki, which is required for pollination. Both new females are, like Issai, bite-sized, can be eaten unpeeled and are sweeter and more aromatic than larger kiwi fruits. Jumbo has relatively large, oblong fruits which are borne in profusion from late September onwards. One potted plant of Jumbo costs £12.95. Pupurna Sadowa has red-skinned fruits with a delicate, slightly sharp taste. This ornamental variety crops heavily, and a potted plant costs £12.95. Both Jumbo and Pupurna Sadowa (http://www. dtbrownseeds. co. uk/catalogue/product/bitesize-kiwi-arguta-purpurna-sadowa-female-/61798) can be supplied with Kiwi Weiki to ensure pollination.

Another new soft fruit is the Balloon Berry, which is also known as the ‘strawberry-raspberry’. It is easy to please and hardy. While the large, sweet fruits are a little bland when raw they make delicious jam and jelly. Its low growing habit makes the Balloon Berry good for ground cover. One potted plant costs £12.95, or three are available for £28.85, saving £10.

Once greenhouses and polytunnels have been cleared of summer crops they often remain unused until the following spring, but D. T. Brown’s ‘undercover’ range of winter greens seeds (http://www. dtbrownseeds. co. uk/search/winter+greens) help to ensure they can remain productive for much more of the year. General manager Tim Jeffries has chosen a varied selection of fast-growing and tasty winter greens, which can be steamed just like spring greens or added to stir-fry dishes and salads. Autumn sowing of the seeds will give speedy crops of healthy and nutritious young vegetables

Sprouting Chinese Cabbage Eats, Shoots and Leaves F1 is not to be missed. Rather like a Chinese purple sprouting, it is much quicker to grow and produces masses of slender, succulent, sweet flower stems which can be eaten raw or lightly steamed. Treat the young leaves just like spinach for a really worthwhile, dual-purpose vegetable. The range also includes Tatsoi Emperor’s Savoy, which resembles a rather flat pak choi, Japanese Spinach Hohei F1, green-stemmed Pak Choi Yuushou F1 and Mizuna Waido, a versatile, cut-and-come-again strain. Autumn and winter sowings should be made in cell packs for transplanting to the greenhouse border. The Undercover Collection of all five varieties is priced at £5.95, a saving of £2.00 on individual prices. 

Other new additions to the vegetable section of the catalogue include a selection of seed mats (http://www. dtbrownseeds. co. uk/catalogue/product/summer-salad-seed-tape-collection/61473/) and seed tapes, which are convenient for both new and seasoned gardeners, autumn-planting Onion Swift, which becomes ready the following May, and Garlics Tuscany Wight and Aquila Wight. Tuscany Wight is widely used in Umbrian chicken dishes and Aquila Wight is a red-skinned Roman type which keeps very well. All D. T. Brown garlic is UK-grown and therefore very well suited to British growing conditions. 

In addition to six ‘second cropping’ new potatoes for autumn and Christmas harvest, the company is also offering a selection of its main season seed potatoes for December delivery to satisfy the many keen growers who ‘chit’ their tubers early.

Back to soft fruit, D. T. Brown’s reputation as one of the leading mail order suppliers will be further enhanced by many exciting new introductions. Gooseberry Xenia’s (http://www. dtbrownseeds. co. uk/catalogue/product/gooseberry-xenia/61724/) large and very sweet fruits can be eaten straight from the spine-free bush if desired. The berries are ready at the end of June and are superb in all types of desserts. One plant of Xenia costs £7.95, while three are priced at just £19.85.

Raspberry Polka has the renowned Autumn Bliss as one of its parents, but it can produce up to double the yield and crop up to two weeks earlier, from late July through to October. The fruits are large, medium red and have a traditional fragrant, zesty flavour. Polka has the added advantage of growing well on a wide range of soils. Six canes cost £12.95 while 12 may be ordered for £21.90. New from Oregon USA is Blackberry Black Pearl, which is currently undergoing commercial trials in the UK. D. T. Brown, customers have the exclusive opportunity to try this thornless and very tasty new variety before it reaches the shops, with one potted plant of Black Pearl costing £8.95 and three costing £17.95.

No summer is complete without strawberries. D. T. Brown has several new varieties on offer in the catalogue. Christine is an ‘early’ which yields plenty of large, firm fruits which are packed with flavour – plus the advantage of strong resistance to most common diseases. A pack of 12 runners costs £12.95. Elegance is a mid season variety, the firm flesh of which is simply packed with flavour. It is an exceptionally heavy cropper. Twelve runners of Elegance cost £9.95.

In recent years D. T. Brown has introduced several outstandingly tasty strawberries from France, the latest of which is early cropping Combraille. With fruits weighing up to 26gm each, it is remarkably large fruited and lacks nothing in flavour, texture and colour. Five runners of Strawberry Combraille are priced at £5.95, while customers may but 15 runners for the price of 10 at £11.90.

Misted tip modules of Strawberry Sonata are again a feature of the catalogue due to their great popularity with ’savvy’ gardeners. A technique developed with commercial producers in mind ensures that if the specially prepared, large young plants are set before the end of August they will yield an earlier and heavier crop next summer – up to 1kg of strawberries per plant. Twelve misted tip plants of Strawberry Sonata cost £12.95.
More…

Blueberries have become increasing popular with British gardeners in recent years. D. T. Brown’s new variety Sunshine Blue is rather different from most in being evergreen or semi-evergreen, giving it greater ornamental value. It grows to around 1m and is perfect for both container and open ground plantings. Showy, bright pink flowers are followed in midsummer by delicious, tangy little fruits. One established three-litre potted plant of Sunshine Blue costs £14.95, while three are priced at £29.85.

While the catalogue is chiefly aimed at kitchen gardens a range of flowers and other ornamental plants is also included. In response to customer demand, D. T. Brown is introducing a range of native, ornamental or edible hedging (http://www. dtbrownseeds. co. uk/search/edible+hedging). Sloe, hazel, sweet briar, copper beech and hornbeam are just some of the species on offer as two-year-old bare-roots. Perfect for naturalistic plantings, they not only look good but provide welcome shelter for a wide range of wildlife.

Few flowers are better loved than sweet peas – and what better ones to grow than those regularly chosen by keen exhibitors? D. T. Brown has carefully selected six of the best ‘showbench’ varieties which it is offering as autumn-sown plants to produce the finest and longest lasting display of these fragrant favourites next season (2011). They can be bought as single varieties or as a money-saving collection of all six for delivery in March 2011.

To request a free copy of the D. T. Brown Summer Fruit and Vegetables Catalogue 2010 (http://www. dtbrownseeds. co. uk/catalogue_request), write to D. T. Brown, Bury Road, Newmarket, Suffolk CB8 7PQ, telephone 0845 3710532, fax 0845 3710534 or visit the D T Brown website (http://www. dtbrownseeds. co. uk).

###

EXCELLENT NEW ALTERNATIVE MEDICINE WEBSITE

EXCELLENT NEW ALTERNATIVE MEDICINE WEBSITE

.20 -

Stock Symbol: WAME (PRWEB) November 23, 2000
Shares Outstanding: 30,000,000

Float: 7,000,000

52 Week Trading Range: $ $3.625

Current Price $3.00

Target Price: $9.00

***********************************************************

About the Company

FRESNO, Calif--In an effort to prepare for expected growth in corporate development, employees, and revenue, WellnessAmerica

( OTC BB: WAME ) announced that it has closed an initial $8 million round of funding with a pledge of an additional $60 million expected to close within the next two months. The proceeds will aid WellnessAmerica, Inc. in its acquisition and corporate development campaign that is anticipated to drive the Company to become a leader in the Alternative Health E-Commerce arena. The Company has designed a program that allows subscribers to have access to the world's largest electronic encyclopedia of alternative medicine gathered under one domain on the Internet.

Reasons to Own the Stock

WellnessAmerica is committed to it's B2B licenses allowing it's partners to build relationships with consumers and health care providers generating revenues thru several methods including licensing fee's from physicians, ad revenues, subscriptions, content value and portal retail sales of vitamins, herbs, skin care products, video, magazines, newsletters, page review fee's paid by search engines, licensee fee's from content syndicated, as well as product portals linked back to WellnessAmerica home products.

Tariq Faridi, President and CEO of Wellness America Inc, "We are experiencing overwhelming demand, and acceptance of our products and services. This is just another step towards our goal of becoming the dominant Alternative Health Therapy Company. This is a very exciting time for us with the trend in health care moving towards Alternative Medicines. With countries like Japan requiring that alternative medicines be used prior to prescription medicines a much larger market is being created. WellnessAmerica is positioning itself to facilitate business in this $90 billion dollar a year marketplace.''

Final Note

Serious investors due their own due diligence about this or any other investment opportunity. The alternative medicine market of over 20 million consumers has spent almost $6 billion on vitamin and weight loss products in the last 10 months alone and is definitely an industry to consider investing in.

New Low-Impact Exercise Video from Joslin Diabetes Center; A Unique Video for Type 2 Diabetes and Pre-Diabetes

New Low-Impact Exercise Video from Joslin Diabetes Center; A Unique Video for Type 2 Diabetes and Pre-Diabetes

Joslin Diabetes Center in Boston, the world leader in diabetes research and care, announced today that it has released Keep Moving!Â…Keep Healthy with Diabetes, the first video designed by Joslin Diabetes Center specifically for people with diabetes or pre-diabetes. Created by the Exercise Physiology Department at Joslin, the video offers low-impact exercises designed for people who have physical limitations or are new to exercise programs. These exercise routines have been used by Joslin patients as part of JoslinÂ’s clinical practice, and can be an ideal tool for those looking for low-impact exercises to help get the physical activity they need.

Boston, MA (PRWEB) July 23, 2004

The Keep Moving!Â…Keep Healthy with Diabetes video costs $24.95, and is available by calling

Joslin at 800-344-4501 or by visiting JoslinÂ’s online store at www. store. joslin. org.

Exercise is an important way to delay or prevent the onset of type 2 diabetes as well as to improve the health of people with diabetes. A recent Joslin Diabetes Center study showed that obese adults who lost just seven percent of their weight – or 16 pounds in a 220-pound, 5'5" tall woman – and did moderate-intensity physical exercise for six months such as the exercises on the Keep Moving! video, improved their major blood vessel function by approximately 80 percent, regardless of whether or not they had type 2 diabetes.

"Physical limitations often prevent many people who want to improve their fitness from doing so, but these limitations do not need to stop them from exercising. In fact for people with physical limitations, having a regular exercise routine is very important since they otherwise tend to lead sedentary lives," said Cathy Mullooly, M. S., R. C.E. P., C. D.E., Clinical Exercise Physiology Specialist at Joslin. "This is a unique resource, especially for those with type 2 diabetes. It is also beneficial for those struggling with their weight and who either should not or cannot embark on a high-impact exercise routine. This video is a great resource for people who assume that fitness is unattainable."

The video shows two simultaneous exercisers, one seated and one standing, performing similar aerobic activities. Seated exercises are appropriate for individuals with a limited capacity for exercise as well as for people with physical limitations (hip or knee problems, balance difficulties, etc.). The standing version involves a higher level of aerobic activity, but is still relatively “low impact.”

Each workout segment is set to music and led by Joslin Clinical Exercise Physiologist Catherine Jarema, M. S., R. C.E. P., C. D.E. Richard A. Jackson, M. D., a senior physician at Joslin Diabetes Center and head of its federally funded "On the Road" program, also provides useful information regarding the correct methods for performing exercises. The entire video runs 45 minutes.

The production of the video was supported by funding from the Cooperative State Research, Education and Extension Service, a division of the United States Department of Agriculture. "On the Road" is a program established by Joslin Diabetes Center to reach out to underserved populations at risk for diabetes.

About Joslin Diabetes Center

Joslin Diabetes Center, dedicated to conquering diabetes in all of its forms, is the global leader in diabetes research, care and education. Joslin Research is a team of over 300 people at the forefront of discovery aimed at preventing and curing diabetes. Joslin Clinic, affiliated with Beth Israel Deaconess Medical Center in Boston, the nationwide network of Joslin Affiliated Programs, and the hundreds of Joslin educational programs offered each year for clinicians, researchers and patients, enable Joslin to develop, implement and share innovations that immeasurably improve the lives of people with diabetes. As a nonprofit, Joslin benefits from the generosity of donors in advancing its mission. For more information on Joslin, call 1-800-JOSLIN-1 or visit www. joslin. org.

Note for Media: A color image of the exercise video cover can be downloaded at the following link:

Http://www. joslin. org/images/exerciseblueborder. jpg (http://www. joslin. org/images/exerciseblueborder. jpg)

###

Relief from IBS using Quantum Focusing and Hypnotherapy

Relief from IBS using Quantum Focusing and Hypnotherapy

Now there’s a light at the end of the tunnel for millions living With IBS -- new protocol wins “Pen and Quill” award.

Tarzana, CA (PRWEB) November 15, 2005

Jack Wilson, C. Ht. is proud to announce the opening of offices in Tarzana and Los Angeles, CA.

Wilson is using a new Quantum Focusing protocol developed by Michael Ellner, D. D., MSH, CHT, and Alan Barsky, CHT, MH and impressive improvements in clients has been observed even after the first session.

Michael Ellner is the recipient of the prestigious "Pen and Quill" Award for his new textbook for Hypnosis Practitioners: QUANTUM FOCUSING with CLIENTS - A Ten-Week Protocol for Relieving Symptoms of IBS - Irritable Bowel Syndrome, co-written with Alan Barsky. The Award was presented at the International Medical and Dental Hypnotherapy Association (IMDHA) 18th Annual Hypnosis Conference.

Hypnosis has been scientifically demonstrated to be helpful in reducing the symptoms of IBS and can improve the quality of life for the estimated 57 million Americans now living with this expensive, painful and very embarrassing condition.

Ellner, an internationally acclaimed hypnosis practitioner and educator, and Barsky, a highly respected hypnosis practitioner in his own right, have developed a Protocol that is designed to help people learn creative, new ways to manage and regulate their bodies' reactions to stress. According to Ellner, "There is light at the end of the tunnel for the tens of millions of people living with IBS. This simple 10-week protocol is designed to help people take charge of their lives and their health." http://www. quantumfocusing. com (http://www. quantumfocusing. com)

Wilson’s most recent studies include gaining certification through the Hypnotherapists Union Local 472 - #AL011462 as well as becoming a Certified NLP Practitioner at the Hypnosis Motivation Institute in Tarzana, CA. http://www. hypnosis. edu (http://www. hypnosis. edu)

As your Quantum Focusing Coach, Wilson will provide you with a Client’s Workbook explaining the step-by-step procedure and forms necessary to maintain a progress history during the sessions. The client must have been evaluated and diagnosed by a licensed medical doctor before beginning the sessions.

In addition to helping clients with IBS, Wilson also uses the latest techniques of Hypnotherapy and NLP in dealing with such things as Fears & Phobias, Low Self-esteem, Self-confidence, Anxiety, Study Habits, Weight Management, Smoking cessation and more. Each session is just about You!

# # #